Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Crispr Therapeutics AG (1CG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.0000 0.0000    0.00%
04/02 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  CH0334081137 
S/N:  A2AT0Z
  • Volume: 0
  • Bid/Ask: 41.0000 / 41.2000
  • Day's Range: 39.4000 - 40.0000
Crispr Therapeutics 40.0000 0.0000 0.00%
Time Frame:
05/17/2019 - 12/02/2021
 
Date Price Open High Low Vol. Change %
Jun 28, 2019 40.0000 39.4000 40.0000 39.4000 0.09K 1.01%
Jun 27, 2019 39.6000 38.2000 39.6000 38.2000 0.42K 1.02%
Jun 26, 2019 39.2000 39.2000 39.2000 38.2000 0.02K 0.51%
Jun 25, 2019 39.0000 37.4000 39.2000 37.4000 0.13K 1.56%
Jun 24, 2019 38.4000 40.4000 40.4000 38.4000 1.61K -4.48%
Jun 21, 2019 40.2000 38.8000 40.2000 37.8000 0.73K 1.52%
Jun 20, 2019 39.6000 41.2000 42.0000 39.6000 0.90K -7.48%
Jun 19, 2019 42.8000 43.0000 44.0000 42.6000 1.66K 0.00%
Jun 18, 2019 42.8000 41.6000 42.8000 40.6000 1.39K 1.90%
Jun 17, 2019 42.0000 38.8000 42.0000 38.4000 2.47K 7.69%
Jun 14, 2019 39.0000 38.8000 40.8000 38.8000 1.41K -0.51%
Jun 13, 2019 39.2000 38.2000 39.2000 38.2000 0.24K 1.55%
Jun 12, 2019 38.6000 38.0000 38.6000 38.0000 0.82K 4.32%
Jun 11, 2019 37.0000 38.6000 39.8000 37.0000 0.54K -1.60%
Jun 07, 2019 37.6000 36.0000 38.0000 36.0000 0.46K 15.34%
Jun 06, 2019 32.6000 33.0000 33.0000 32.6000 - -2.40%
Jun 05, 2019 33.4000 33.0000 33.6000 32.8000 0.34K 1.21%
Jun 04, 2019 33.0000 31.6000 33.0000 31.6000 0.42K 4.43%
Jun 03, 2019 31.6000 31.2000 31.8000 31.2000 0.26K -3.07%
May 31, 2019 32.6000 32.6000 32.6000 32.0000 0.12K -0.61%
May 30, 2019 32.8000 32.8000 32.8000 32.8000 0.05K 2.50%
May 29, 2019 32.0000 32.6000 32.6000 32.0000 0.03K -3.61%
May 28, 2019 33.2000 33.4000 33.4000 32.8000 1.12K 0.00%
May 27, 2019 33.2000 32.8000 33.2000 32.8000 0.00K 0.00%
May 24, 2019 33.2000 32.6000 33.2000 32.6000 0.15K -0.60%
May 23, 2019 33.4000 34.4000 34.4000 33.4000 - -4.02%
May 22, 2019 34.8000 35.0000 35.0000 34.8000 - -0.57%
May 21, 2019 35.0000 33.4000 35.0000 33.4000 1.50K 3.55%
May 20, 2019 33.8000 35.0000 35.0000 33.8000 - -3.98%
May 17, 2019 35.2000 35.0000 35.4000 34.6000 0.71K -12.00%
Highest: 44.0000 Lowest: 31.2000 Difference: 12.8000 Average: 36.4933 Change %: 0.0000
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about CRISPR Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Marco Castañeda
Marco Castañeda Nov 23, 2021 12:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignanciesZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) http://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-announces-fda-regenerative-medicine-advanced
jason xx
jason xx Nov 18, 2021 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Amazing how fast this went from breakthrough life changing technology to garbage in about a month
jason xx
jason xx Nov 18, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
One paragraph of good news and this goes back to 160 in a day after the sheep pile in. Not just this ticker but any of them.
Benjamin Kim
Benjamin Kim Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Added 1100 shares
sharad sharma
sharad sharma Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now u must be regretting
Benjamin Kim
Benjamin Kim Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nope I'm long!
Lucky Man
Lucky Man Oct 29, 2021 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep tanking this stock what a hopeless
Abdulla Amiri
Abdulla Amiri Oct 18, 2021 2:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ouch
John Doe
John Doe Oct 15, 2021 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In few weaks 120
Financial Advisors
Financial Advisors Oct 15, 2021 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why are you so sure Mr. John Doe ? please ?
John Brand
John Brand Oct 15, 2021 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possible. 102 is more likely. If it does approach 120, breaking 124 resistance will be a signifant upside challenge.
Fabrizio Lombardo
Fabrizio Lombardo Oct 15, 2021 4:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
in 4 weeks 85
Barak David
Barak David Oct 12, 2021 5:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ouch. well since we're here.. i might as well average down
Fabrizio Lombardo
Fabrizio Lombardo Oct 05, 2021 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
median bollinger band is broken on monthly TF... waiting the end of october...
Fabrizio Lombardo
Fabrizio Lombardo Sep 16, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
97 usd  is a good entry point...
Nuno Da Silva
Nuno Da Silva Aug 30, 2021 1:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a classic Cathy wood collapse
Jonathan badham
Jonathan badham Aug 17, 2021 7:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how do you actually buy shares i have a buy sell window open but its an ad i wanna actually buy a stock not be sent to yet another bs broker app
steve loeschke
steve loeschke Aug 17, 2021 7:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Check if you Bank can help you out
John Brand
John Brand Aug 17, 2021 7:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Open and fund a brokerage account. There are many options.
Barak David
Barak David Aug 02, 2021 3:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow
Ray Weber
Ray Weber Jul 29, 2021 5:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Beat on earnings!! Largly
kyle dvorsky
kyle dvorsky Jul 26, 2021 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Problem with this one is you're gonna need to wait a literal decade for it to be viable, regardless of studies/tests.
palmer gossett
palmer gossett Jul 26, 2021 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
true
Ray Weber
Ray Weber Jul 26, 2021 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think in a normal world… Definitely. My opinion, it right around the corner.
Nuno Da Silva
Nuno Da Silva Jul 26, 2021 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
total bubble of cathie wollod pump
도리 Dori
도리 Dori Jul 19, 2021 3:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CRSP and AIRI are Good stockAIRI will go up to X3
palmer gossett
palmer gossett Jul 13, 2021 7:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep on dropping...
Nuno Da Silva
Nuno Da Silva Jul 08, 2021 9:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good entry point is around 80
palmer gossett
palmer gossett Jul 06, 2021 8:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep dropping, want to get back in
Ray Weber
Ray Weber Jul 05, 2021 6:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
206 by Oct
Adam Anderson
Adam Anderson Jul 05, 2021 6:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That would be acceptable.
Serdar Altinel
Serdar Altinel Jul 02, 2021 4:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Last weekend, Intellia Therapeutics and Regeneron announced first-ever clinical data that support the safety and efficacy of in vivo CRISPR genome editing in humans. We summarise the findings here.
Pro Investor
Pro Investor Jun 30, 2021 6:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ride it to new highs
Mayadachi Ikechi
Mayadachi Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alert: Crispr Therapeutics will acquire AGTC before end of FY2021 as a strategy to get into the ophthalmology space. Load up now & Stay tuned
palmer gossett
palmer gossett Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ok, thanks
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thank you, but may we know your source, please?
Mary Miller
Mary Miller Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What proof or source do you have that these facts have changed? See quote:  Gene therapy developer AGTC lost nearly half its market cap Thursday morning after Biogen exited a collaboration agreement on the heels of a big clinical failure. Interim six-month data on one of AGTC's investigational therapies showed it was generally safe but ineffective at treating a rare eye disorder known as X-linked retinoschisis (XLRS). The company plans to complete patient monitoring activities on the XLRS program but will not develop it further.
Neek Kajula
Neek Kajula Jun 28, 2021 7:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Held the dip, looks great
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email